This issuer’s offering is insured by the TigerMarkTM insurance policy. Please click here to learn more about this policy.
Rejuvine Life Sciences is revolutionizing the natural health sector by combining ancient wisdom with modern science. Our flagship product, Skordo Plus, offers a groundbreaking, scientifically-backed herbal solution for diabetes management. Developed over seven years and protected by patents, Skordo Plus represents a holistic approach to blood sugar control and overall well-being, setting a new standard in the herbal supplement market. Join us in fostering a healthier future.
Highlights
- Significant Health Impact: Skordo Plus targets the 38.4 million diabetics in the U.S., addressing a major health concern.
- Lucrative Market Entry: Enters the $50.1 billion U.S. herbal supplement market, tapping into the growing anti-diabetic sector valued at $33.54 billion.
- Focused Solutions: Specializes in diabetes management, with additional products for women’s health and pain relief.
- Patent Protection: Holds U.S. and Indian patents for its unique anti-diabetic formulations.
- Scientific Validation: Commitment to scientifically validated, safe, and effective herbal products.
- Integrating Tradition with Science: Merges traditional herbal knowledge with modern scientific research.
- Global Presence: Operates in India, Singapore, and the U.S., addressing diverse international health needs.
- Robust R&D Investment: Dedicated to developing innovative herbal solutions through substantial R&D efforts.
Diabetes Care: Protecting Vital Health
Rejuvine Life Sciences tackles the multifaceted challenges faced by individuals living with diabetes. Our primary focus is on patients struggling to manage their blood sugar levels effectively, a condition that can lead to a cascade of health complications. This includes the vulnerability of vital organs like the heart, liver, and kidneys. We also recognize the importance of overall well-being, and conditions such as appetite problems, frequent urination, disrupted sleep, and a general slowdown in the body's ability to rejuvenate itself.
A Personal Mission in Diabetes Care
Many of us at Rejuvine Life Sciences have a personal connection to diabetes, either through ourselves or our loved ones. This deepens our commitment to developing solutions that empower individuals with diabetes to take a more active role in managing their health. We understand the limitations and potential side effects of conventional treatments, driving the search for safer and more holistic solutions like Skordo Plus, Krewsano, and Ostasano. Our goal is to move beyond short-term fixes and provide long-term, sustainable support that fosters overall well-being and a healthier future for those living with diabetes.
Competitive Landscape
The diabetic supplement market is crowded with established and emerging players like GlucoControl, Blood Sugar Ultra, and DiabetACE. While these competitors offer various formulations with vitamins, minerals, and herbal extracts, they often lack a specific focus. Their generic marketing approach and broad product lines might not address the diverse needs of individuals with diabetes. Ben's Natural Health focuses on a single product for type 2 diabetes, emphasizing its effectiveness and scientific backing. However, their high price point compared to some competitors and limited product range might hinder their reach.
The Skordo Plus Advantage
Rejuvine Life Sciences stands out in the diabetic supplement market by not only managing blood sugar but also focusing on overall well-being and protecting vital organs. Our science-backed, holistic approach is showcased in our flagship product, Skordo Plus, uniquely formulated for maintaining healthy blood sugar levels and safeguarding vital organs. This commitment to safety, long-term support, and a clinically validated approach sets us apart, offering a comprehensive solution for individuals with diabetes.
Market Size
The US diabetic supplement market offers a promising revenue avenue for Rejuvine Life Sciences. With 38.4 million Americans living with diabetes and a market valued at $33.54 billion, the demand for effective, natural solutions is clear. Rejuvine aims to tap into this market with Skordo Plus, leveraging our commitment to scientific integrity, quality, and a holistic approach.
Our strategy
Our strategy targets both alternative medicine aficionados and the broader diabetic community, combining natural ingredients with solid scientific backing and healthcare collaborations. This dual approach positions Skordo Plus not only as a trusted product for health-conscious individuals but also as a strong player in the growing US anti-diabetic sector.
Solution
Skordo Plus and Diabetes Management: We tackle diabetes with Skordo Plus, a research-backed solution formulated with a unique blend of ingredients. This blend promotes holistic blood sugar management by supporting healthy blood sugar levels, safeguarding vital organs, regulating appetite, improving sleep, and encouraging natural rejuvenation. Skordo Plus prioritizes safety with minimal side effects and empowers individuals with a sustainable, long-term approach to managing their diabetes and improving overall well-being.
Expanding Our Reach: In addition to Skordo Plus, we offer Krewsano, a product designed to support bone health in women, and Ostasano, which promotes healthy red blood cell production. We're also developing a revolutionary pain relief medication that aims to effectively manage pain while minimizing or eliminating the side effects associated with current options.
Rejuvine Life Sciences earns revenue through direct sales and partnerships. Our scientifically validated herbal formulations, like Skordo Plus for diabetes management, Krewsano for bone health, and Ostasano for women's blood health, are available directly to consumers through our online platforms. We also collaborate with retailers to expand our reach. Additionally, Rejuvine partners with healthcare professionals and institutions, and explores distribution agreements to ensure their targeted solutions reach a wider audience struggling with specific health concerns.
Here are three key milestones that demonstrate Rejuvine Life Sciences' traction in the market:
1. Strong Initial Sales & Repeat Customers: In just the past four months, we've sold approximately 600 boxes of our products, with a significant portion of those sales coming from repeat buyers. This early customer loyalty demonstrates the effectiveness of our solutions and the potential for sustained growth.
2. Expanding Distribution Network: We've secured strategic distribution agreements with key partners to increase Rejuvine's reach and accelerate our growth in key international markets.
- Suvego Life Science Pvt. Ltd. (India) - Non-exclusive distribution in Tamil Nadu
- Bifrost Media Pte. Ltd. (Singapore) - Exclusive distribution in Singapore, Malaysia, Indonesia, and the Philippines
- Aram Naturals (North America) - Non-exclusive distribution in the US and Canada
3. Continued Expansion Opportunities: Discussions are underway with potential distributors in the GCC countries and Turkey, further solidifying our commitment to global market access.
What our customers say about Rejuvine Life’s products
Our founding team has played a crucial role in securing the initial funding for Rejuvine Life Sciences. Pat Theenathayalan and Sudhir Agrawal provided a significant financial investment, contributing $386,552 and $114,000 respectively. Beyond their financial contributions, Mr. Theenathayalan and Mr. Agrawal have invested a considerable amount of time and effort in running the company's day-to-day operations.
Equally important is the dedication of our scientific team, led by Dr. Deepa. Dr. Deepa and her team have poured their expertise into research and development for over seven years, culminating in the creation of Skordo Plus. This commitment extends beyond Skordo Plus, as they have also dedicated over three years to other ongoing research initiatives.
Team
Rejuvine Life Sciences is building a powerful team to transform natural healthcare. We combine extensive experience with diverse perspectives to achieve our goals.
Leading the team is Dr. Deepa, a seasoned medicinal plant researcher. Her deep knowledge and dedication inspire the team. Alongside Dr. Deepa are meticulous scientists who rigorously test and validate every herbal formulation, ensuring they align with our vision and mission.
Pat Theenathayalan steers the company's direction using his sharp business sense, drawing on his experience of having exited from his tech startup. Financial and legal expertise are provided by Sudhir Agrawal, guaranteeing long-term sustainability. Bridging traditional and modern medicine, Dr. Gasel Muhammed, an Ayurvedic Physician, offers medical leadership. Finally, Dr. Subash Imanuel, a renowned Pulmonologist, ensures the safety and effectiveness of our solutions.
The intended use of funds at the minimum amount raised is to cover essential operational costs, such as research and development, marketing, and initial staffing needs. Additionally, our focus will be on securing intellectual property (IP) protection for our formulations through patents and ensuring regulatory compliance to meet the standards for different markets.
Additional funding will be used toward:
At the maximum amount raised, the funds will be allocated towards scaling up operations significantly. This includes expanding research and development efforts to enhance product efficacy, intensifying marketing strategies to reach broader audiences, bolstering manufacturing capabilities to meet increased demand, and further strengthening our team with additional talent. Additionally, a substantial portion of funds will be allocated towards securing intellectual property (IP) protection for our formulations through patents and ensuring rigorous regulatory compliance across various markets.
Rejuvine Life Sciences is targeting to achieve break-even within the first year of operation. This goal leverages the seven years of R&D already invested in our flagship product, Skordo Plus. Additionally, our upcoming products aimed at women's bone and blood health are expected to contribute to reaching this target.
However, it's important to note that the break-even timeline hinges on our continued investment in Research and Development (R&D). If further scientific studies are required for new formulations being developed by our scientists, the break-even point may shift to the end of year two.
Rejuvine Life Sciences is committed to providing investors with a clear path to returns. Our business model combines global market potential with strategic partnerships for maximum impact. We project strong sales growth for our innovative products, alongside potential licensing agreements for our unique formulations.
We understand the importance of realistic financial projections. We've adopted a conservative approach, identifying potential risks and implementing mitigation strategies to ensure investor confidence. Transparency is key, and we'll keep investors informed as we navigate challenges and achieve milestones.
Investors can expect returns through multiple avenues. Once we reach profitability (break-even), we plan to issue dividends. Additionally, our innovative products and formulations could attract acquisition by larger companies, providing investors with a significant return.
Early Traction, Strong Future:
While revenue generation has yet to begin, early market indicators suggest a strong foundation for success. We've established industry relationships and alliances that will fuel strategic growth and market penetration, further solidifying our competitive edge and scalability. The repeatability of our processes and positive customer interest validate our business model and pave the way for long-term market success.